Amphastar Pharmaceuticals Inc. (AMPH) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Amphastar Pharmaceuticals Inc. (AMPH:NASDAQ), powered by AI.

Current Price
$19.96
P/E Ratio
9.5
Market Cap
933M
Sector
Healthcare
What is the Amphastar Pharmaceuticals Inc. stock price forecast?

Amphastar Pharmaceuticals Inc. is currently trading at $19.96. View real-time AI analysis on Alpha Lenz.

What is Amphastar Pharmaceuticals Inc. insider trading activity?

View the latest insider trading data for Amphastar Pharmaceuticals Inc. on Alpha Lenz.

What is Amphastar Pharmaceuticals Inc.'s P/E ratio?

Amphastar Pharmaceuticals Inc.'s P/E ratio is 9.5.

Amphastar Pharmaceuticals Inc.

NASDAQ · AMPH
$19.96+0.25(+1.27%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Amphastar Pharmaceuticals Inc.'s future dividend policy...
Alpha Chat Insight

Amphastar Pharmaceuticals Inc. trades at a P/E of 9.5 (undervalued) with solid ROE of 12.9%. 3Y revenue CAGR of 13.0% highlights clear growth momentum.

Ask for details

Company Overview

Amphastar Pharmaceuticals Inc. is a specialty pharmaceutical company dedicated to the development, manufacture, and marketing of innovative generic and proprietary injectable, inhalation, and intranasal products. Amphastar's primary function is to provide cost-effective medications that improve patient care and accessibility to treatment. The company’s product portfolio includes critical drugs used in hospitals and other medical settings, targeting areas like endocrinology, anesthesia, and pain management. Amphastar Pharmaceuticals impacts the healthcare industry significantly by supplying generic alternatives to high-cost brand-name drugs, greatly aiding healthcare systems in managing medication expenditures. Headquartered in Rancho Cucamonga, California, Amphastar operates both in the United States and internationally, emphasizing rigorous quality control and regulatory compliance in its production processes. The company plays a vital role in the healthcare market by ensuring a steady supply of essential medicines, helping to alleviate shortages and support the delivery of efficient medical care.

CEODr. Yongfeng Zhang Ph.D.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,028

Company Statistics

FY 2025

Profile

$932.99MMarket Cap
$719.89MRevenue
0.00Shares Out
2,028Employees

Margins

49.46%Gross
29.49%EBITDA
19.50%Operating
17.17%Pre-Tax
13.63%Net

Valuation

9.51P/E
1.18P/B
1.30EV/Sales
6.68EV/EBITDA
7.84P/FCF

Growth (CAGR)

12.99%Rev 3Yr
15.53%Rev 5Yr
9.31%Op Inc 3Yr
66.56%Op Inc 5Yr
2.39%Net Inc 3Yr
145.63%Net Inc 5Yr

Returns

6.12%ROA
12.90%ROE
9.30%ROIC

Financial Health

$170.18MCash & Cash Equivalents
$670.32MNet Debt
106.55%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Amphastar Pharmaceuticals Inc. (ticker: AMPH) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,028 employees. Market cap is $933M.

The current price is $19.96 with a P/E ratio of 9.51x and P/B of 1.18x.

ROE is 12.90% and operating margin is 19.50%. Annual revenue is $720M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Amphastar Pharmaceuticals Inc. (AMPH) Stock Forecast 2026 $19.96 — Price, Financials & Analyst Targets | Alpha Lenz